Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry

G Bsteh; H Assar; C Gradl; B Heschl; MS Hiller; N Krajnc; F Di Pauli; H Hegen; G Traxler; Peter Wipfler; M Guger; C Enzinger; T Berger

Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry

G Bsteh, H Assar, C Gradl, B Heschl, MS Hiller, N Krajnc, F Di Pauli, H Hegen, G Traxler, Peter Wipfler, M Guger, C Enzinger, T Berger

Department of Neurology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	487-488
Journal	MULTIPLE SCLEROSIS
Volume	28
Issue number	3_SUPPL
Publication status	Published - 2022

Cite this

Bsteh, G., Assar, H., Gradl, C., Heschl, B., Hiller, MS., Krajnc, N., Di Pauli, F., Hegen, H., Traxler, G., Wipfler, P., Guger, M., Enzinger, C., & Berger, T. (2022). Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry. MULTIPLE SCLEROSIS , 28(3_SUPPL), 487-488.

Bsteh, G ; Assar, H ; Gradl, C et al. / Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry. In: MULTIPLE SCLEROSIS 2022 ; Vol. 28, No. 3_SUPPL. pp. 487-488.

@article{4b3bb4adb94d4c03b736c864f1309805,

title = "Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry",

author = "G Bsteh and H Assar and C Gradl and B Heschl and MS Hiller and N Krajnc and {Di Pauli}, F and H Hegen and G Traxler and Peter Wipfler and M Guger and C Enzinger and T Berger",

year = "2022",

language = "English",

volume = "28",

pages = "487--488",

journal = "MULTIPLE SCLEROSIS ",

issn = "1352-4585",

number = "3_SUPPL",

}

Bsteh, G, Assar, H, Gradl, C, Heschl, B, Hiller, MS, Krajnc, N, Di Pauli, F, Hegen, H, Traxler, G, Wipfler, P, Guger, M, Enzinger, C & Berger, T 2022, 'Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry', MULTIPLE SCLEROSIS , vol. 28, no. 3_SUPPL, pp. 487-488.

Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry. / Bsteh, G; Assar, H; Gradl, C et al.
In: MULTIPLE SCLEROSIS , Vol. 28, No. 3_SUPPL, 2022, p. 487-488.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry

AU - Bsteh, G

AU - Assar, H

AU - Gradl, C

AU - Heschl, B

AU - Hiller, MS

AU - Krajnc, N

AU - Di Pauli, F

AU - Hegen, H

AU - Traxler, G

AU - Wipfler, Peter

AU - Guger, M

AU - Enzinger, C

AU - Berger, T

PY - 2022

Y1 - 2022

M3 - Abstract (Journal)

SN - 1352-4585

VL - 28

SP - 487

EP - 488

JO - MULTIPLE SCLEROSIS

JF - MULTIPLE SCLEROSIS

IS - 3_SUPPL

ER -

Bsteh G, Assar H, Gradl C, Heschl B, Hiller MS, Krajnc N et al. Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry. MULTIPLE SCLEROSIS . 2022;28(3_SUPPL):487-488.